Drugs / Azintamide
Azintamide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04786795 | Mar 2021 → Feb 2022 | postcholecystectomy syndrome | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Azintamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04786795 ↗ |
| Known as | Azintamida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104678 ↗ |
| Known as | Colerin | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104678 ↗ |
| Known as | NSC-291837 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104678 ↗ |
| Known as | ST 9067 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104678 ↗ |
| Modality | Small molecule | — CHEMBL2104678 ↗ |